Fludarabine
Plasma Cell Dyscrasia
Affiliated Hospital to Academy of Military Medical SciencesSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
20 Active assets in the Plasma Cell Dyscrasia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Hellenic Society of Hematology | Phase 3 | BBB |
cc-5013 Hellenic Society of Hematology | Phase 3 | BBB |
Cyclophosphamide Affiliated Hospital to Academy of Military Medical Sciences | Phase 3 | BB |
Fludarabine Affiliated Hospital to Academy of Military Medical Sciences | Phase 3 | BB |
FILGRASTIM Hellenic Society of Hematology | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →